[Hankyung] Lee & Ko Prevails in All 10 Lawsuits Relating to Boryung Pharmaceutical’s Ducarb® Patent

On December 5, 2023, Hankyung reported Lee & Ko’s recent win in the lawsuits involving Boryung Pharmaceutical’s combination drug patent related to Ducarb®, Boryung’s blockbuster drug.  Representing the patentee, Lee & Ko won in all 10 cases, which included patent invalidation actions and negative scope confirmation actions.  Lee & Ko’s team, with attorneys Keum Nang Park, Heon Lee and Eunkyoung Lyu and patent attorneys Tae Min Kim and Sungmin Cho, strategically crafted arguments based on sound and in-depth analysis of legal theories, ultimately securing this victory.